59 results
Page 2 of 3
424B7
xi8ud07nzr
23 Nov 21
Prospectus with selling stockholder info
4:06pm
F-3
ovhj q4tv22ltq
10 Nov 21
Shelf registration (foreign)
5:23pm
6-K
EX-99.1
3utk mcrwadu
4 Nov 21
Index to Unaudited Condensed Consolidated Financial Statements
7:21am
6-K
EX-99.2
orjzsybv
4 Nov 21
Index to Unaudited Condensed Consolidated Financial Statements
7:21am
6-K
EX-99.2
fe32og a0mpg9sp
5 Aug 21
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.1
x03nq
27 Jul 21
Current report (foreign)
6:12am
6-K
EX-99.3
c8grmvy
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.1
p3wttm 24pjo
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.2
cubtgg1qbt 4vrl
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.1
4rlofcdo06gqq1v
22 Apr 21
ObsEva Annual General Meeting 2021
6:31am
424B5
mxkjv2h528toc z7c
5 Mar 21
Prospectus supplement for primary offering
7:55am
6-K
EX-99.1
rsgdd3
5 Mar 21
ObsEva Announces Year End 2020 Financial Results
7:21am
6-K
EX-99.1
wreveaq6w ecyi0
10 Feb 21
ObsEva Provides Business Outlook for 2021
6:10am
424B5
e6yhv1m
8 Sep 20
Prospectus supplement for primary offering
7:31am
6-K
EX-99.1
qzzs9ad0wkf5zi56yxd
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.1
pruvnvb4s5l1v4ynu7ie
1 Jul 20
ObsEva and Yuyuan BioScience Technology Announce Submission of the Pre-IND Dossier for Nolasiban with the Chinese NMPA
6:15am
6-K
EX-99.1
phd67id
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am